We are live on ! Find out more
Russell Investments Group

Russell Investments Group Portfolio holdings

AUM $114B
1-Year Est. Return 41.71%
This Fund
S&P 500
This Quarter Est. Return
+8.42%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
AUM
$69.1B
AUM Growth
+$6.99B
Cap. Flow
+$1.68B
Cap. Flow %
2.44%
Top 10 Hldgs %
21.7%
Holding
3,863
New
279
Increased
1,682
Reduced
1,438
Closed
180

Sector Composition

Rank Sector Weight
1 Technology 24.83%
2 Financials 12.81%
3 Healthcare 11.02%
4 Consumer Discretionary 10.22%
5 Real Estate 8.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWJ icon
3276
iShares MSCI Japan ETF
EWJ
$22.7B
$1.93K ﹤0.01%
27
FDMT icon
3277
4D Molecular Therapeutics
FDMT
$600M
$1.89K ﹤0.01%
175
-2,133
-92% -$35.4K
FBT icon
3278
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.81B
$1.89K ﹤0.01%
+11
New +$1.82K
BGFV
3279
DELISTED
Big 5 Sporting Goods
BGFV
$1.89K ﹤0.01%
904
-10,173
-92% -$21.7K
FSTR icon
3280
Foster
FSTR
$397M
$1.88K ﹤0.01%
92
+18
+24% +$366
COGT icon
3281
Cogent Biosciences
COGT
$6.61B
$1.88K ﹤0.01%
174
-2,202
-93% -$21.4K
XBI icon
3282
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$1.88K ﹤0.01%
19
-2
-10% -$197
DLTH icon
3283
Duluth Holdings
DLTH
$152M
$1.84K ﹤0.01%
489
+301
+160% +$1.1K
MOND
3284
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
$1.82K ﹤0.01%
1,307
-37
-3% -$78
RELL icon
3285
Richardson Electronics
RELL
$297M
$1.81K ﹤0.01%
147
ACRV icon
3286
Acrivon Therapeutics
ACRV
$74M
$1.81K ﹤0.01%
258
-911
-78% -$7.18K
ALAB icon
3287
Astera Labs
ALAB
$54.1B
$1.78K ﹤0.01%
+34
New +$1.6K
ASUR icon
3288
Asure Software
ASUR
$243M
$1.77K ﹤0.01%
+196
New +$1.75K
WTBA icon
3289
West Bancorporation
WTBA
$496M
$1.77K ﹤0.01%
93
+39
+72% +$748
PTON icon
3290
Peloton Interactive
PTON
$2.46B
$1.75K ﹤0.01%
375
-835
-69% -$3.28K
SMOT icon
3291
VanEck Morningstar SMID Moat ETF
SMOT
$338M
$1.75K ﹤0.01%
+50
New +$1.66K
VDC icon
3292
Vanguard Consumer Staples ETF
VDC
$7.92B
$1.75K ﹤0.01%
8
ESTA icon
3293
Establishment Labs
ESTA
$2.21B
$1.73K ﹤0.01%
40
AURA icon
3294
Aura Biosciences
AURA
$832M
$1.7K ﹤0.01%
191
-51
-21% -$437
STRS icon
3295
STRATUS PPTYS INC
STRS
$1.69K ﹤0.01%
65
EWCZ
3296
DELISTED
European Wax Center
EWCZ
$1.69K ﹤0.01%
+248
New +$1.93K
PRCT icon
3297
Procept Biorobotics
PRCT
$1.31B
$1.68K ﹤0.01%
21
+9
+75% +$639
MYFW icon
3298
First Western Financial
MYFW
$305M
$1.68K ﹤0.01%
+84
New +$1.53K
BIRK icon
3299
Birkenstock
BIRK
$6.89B
$1.68K ﹤0.01%
34
-9
-21% -$490
OBIO icon
3300
Orchestra BioMed
OBIO
$263M
$1.66K ﹤0.01%
323
-3,527
-92% -$23K

Similar funds

Russell Investments Group's Q3 2024 Portfolio in Review

As of Q3 2024, Russell Investments Group held 3,863 positions worth $69.1B, up 11% from $62.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Russell Investments Group's Q3 2024 filing shows 279 new, 1,682 increased, 1,438 reduced and 180 closed positions. Its largest new stake was Hewlett Packard Enterprise 7.625% Series C Preferred Stock: 1,239,800 shares worth $1.5M. The largest sale was Bank of America Series L, an estimated $861M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • Russell Investments Group's largest Q3 2024 buy was Hewlett Packard Enterprise 7.625% Series C Preferred Stock: 1,239,800 shares worth $1.5M.
  • Russell Investments Group added most to Apple in Q3 2024, an estimated $212M increase.
  • Russell Investments Group's biggest Q3 2024 reduction was Bank of America Series L, cutting an estimated $861M.
  • Russell Investments Group fully exited WestRock Company in Q3 2024, selling an estimated $8.96M.
  • Russell Investments Group's ten largest holdings make up 22% of its $69.1B portfolio in Q3 2024.
  • Russell Investments Group opened 279 new positions and closed 180 in Q3 2024.
  • Russell Investments Group's portfolio value rose 11% quarter-over-quarter to $69.1B.

Based on Russell Investments Group's 13F filing for Q3 2024, filed 13 Nov 2024.